Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma.
Saved in:
| Title: | Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma. |
|---|---|
| Authors: | Hsu, C.-H.1, Yang, T.-S.2, Hsu, C.1, Toh, H. C.3, Epstein, R. J.4, Hsiao, L.-T.5, Chen, P.-J.6, Lin, Z.-Z.1, Chao, T.-Y.7, Cheng, A.-L.1 alcheng@ntu.edu.tw |
| Source: | British Journal of Cancer. 3/15/2010, Vol. 102 Issue 6, p981-986. 6p. 3 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
